Video

Innovations in Surgical Oncology at Roswell Park

In this video, John M. Kane III, MD, FACS, chair of Surgical Oncology and Chief of the Melanoma/Sarcoma Service at Roswell Park, discusses some of the unique aspects of surgical oncology offered at the center and recent innovations in techniques

Video

Dissecting Cutaneous Oncology, One Layer at a Time

Wednesday, February 16th, 2022 | 5:00 - 6:30 PM EST

Video

Benefits of Combining Beta-Blocker and Checkpoint Inhibitor

The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.

Video

Welcome to Roswell Park | Shalana O'Brien, MD

Shalana O'Brien, MD, is a highly skilled surgical oncologist treating patients with melanoma/skin cancers, endocrine disorders and cancers, and specializing in heated chemotherapy (HIPEC) to treat advanced cancers that have spread within the abdomen.

News

Clinical Trial Evaluates Smaller Surgical Margins for Stage 2 Melanoma Patients

Although most primary cutaneous melanomas are treated with surgical excision alone, current international guidelines vary on the optimal size for the surgical margins, which can range from 1 to 3 cm. based on Breslow thickness.

News

Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma

A central question in oncology is how to offer efficacious treatments while minimizing toxicity. This is especially true when treating advanced sarcoma and melanoma of the extremity.

News

Roswell Park Experts Use Gene Sequencing to Quantify Risk of Skin Cancer Long Before Damage is Visible

New findings could lead to better tools for the identification of at-risk individuals, earlier cancer prevention.

News

Use of Pembrolizumab Provided Long-Term Benefits in Patients With Metastatic Melanoma, 10-Year Look Shows

JAMA Oncology provides new insights that survival benefits are held regardless of BRAF mutation status or earlier targeted therapy.